| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 07/15/2004 | WO2002081636A3 Protein modification and maintenance molecules |
| 07/15/2004 | WO2002024216A3 Method for use of igf-binding protein for selective sensitization of target cells in vivo |
| 07/15/2004 | US20040138430 Novel polypeptide compose substance for promoting blood and blood vessel cell growth |
| 07/15/2004 | US20040138427 Chimeric monoclonal antibody for use as diagnostic and immunotherapeutic tool in treatment and prevention of infection, cancer, vascular, autoimmune, neurodegenerative and arthritic diseases; immunoassays |
| 07/15/2004 | US20040138421 ACPL DNA and polypeptides |
| 07/15/2004 | US20040138419 Inhibitor of cell proliferation and methods of use thereof |
| 07/15/2004 | US20040138417 Chimeric heteromultimer adhesins |
| 07/15/2004 | US20040138416 Comprises membrane protein for use in diagnosis prevention and treatment of cell proliferative, neurological, cardiovascular, gastrointestinal, autoimmune, inflammatory, metabolic and viral disorders |
| 07/15/2004 | US20040138415 Helicobacter proteins, nucleic acids and uses thereof |
| 07/15/2004 | US20040138414 Secreted proteins |
| 07/15/2004 | US20040138411 lyophilization of an aqueous mixture comprising a boronic add compound and a compound having at least two hydroxyl groups produces a stable composition that readily releases the boronic acid compound upon dissolution in aqueous media |
| 07/15/2004 | US20040138329 Gels for encapsulation of biological materials |
| 07/15/2004 | US20040138311 medicament enables disturbances of thiol-disulfide status or those that occur, for example, in diabetes melltus to be treated simultaneously, separately or in a temporally graduated manner |
| 07/15/2004 | US20040138304 Prodrugs of excitatory amino acids |
| 07/15/2004 | US20040138296 Amyloid immunization and Cox-2 inhibitors for the treatment of alzheimer's disease |
| 07/15/2004 | US20040138257 Chemical derivatives and their application as antitelomerase agent |
| 07/15/2004 | US20040138231 Pharmaceutical composition which comprise a solid dispersion of a hydroxypropyl-methylcellulose phthalate polymer |
| 07/15/2004 | US20040138175 Peptide boronic acid drug; thrombosis therapy; anticoagulants |
| 07/15/2004 | US20040138170 Viricides; administering nucleoside with anoth compound such as interferons, interleukin or drug |
| 07/15/2004 | US20040138168 Methods and compositions for inhibiting the function of polynucleotide sequences |
| 07/15/2004 | US20040138167 Administering a nucleic acid; prevention infections, Dna damage, tumors,skin disorders |
| 07/15/2004 | US20040138166 Viricides; prevent reproduction, infections |
| 07/15/2004 | US20040138164 Oligonucleotides; nucleic acid; therapy, diagnosis; cardiovascular disorders, atherosclerosis, anticholesterol agents |
| 07/15/2004 | US20040138159 Oligonucletides for regulating the gene coding for tnf$g(a) and/or genes controlled thereby and use thereof |
| 07/15/2004 | US20040138156 Therapeutic regulation of deoxyribonuclease-1-like-3 activity |
| 07/15/2004 | US20040138155 for treatment of central and/or peripheral nervous system injury; neurons; fibroblast growth factor receptors; biocompatability |
| 07/15/2004 | US20040138153 enzyme inhibitors; drug screening |
| 07/15/2004 | US20040138140 Combination cancer therapy with a GST-activated anticancer compound and another anticancer therapy |
| 07/15/2004 | US20040138139 Diaminodicarboxylic acid/peptide gemini surfactants; drug delivery |
| 07/15/2004 | US20040138138 Luteinizing hormone releasing hormone (LHRH); such as cetrolrelix; lowering sex hormone levels |
| 07/15/2004 | US20040138137 Alloferons - immunomodulatory peptides |
| 07/15/2004 | US20040138136 Cyclic peptide compositions and methods for treatment of sexual dysfunction |
| 07/15/2004 | US20040138135 immunogens; immunotherapy; antigen presenting cells |
| 07/15/2004 | US20040138134 Method and composition for treatment of skeletal dysplasias |
| 07/15/2004 | US20040138133 tat genes/proteins; transport proteins; kits; for treating neovascular glaucoma, diabetic retinopathy, retrolental fibroplasia, hemangiomas, angiofibromas, psoriasis, osteoarthritis, rheumatoid arthritis, and cancers |
| 07/15/2004 | US20040138132 Membrane translocating peptide drug delivery system |
| 07/15/2004 | US20040138131 inhibiting virus attachment to hepatocytes via exposing to recombinant urine derived protein |
| 07/15/2004 | US20040138130 Active modified hedgehog proteins |
| 07/15/2004 | US20040138129 for increasing production of reticulocytes and red blood cells; for treatment of anemia/renal failure/cancer |
| 07/15/2004 | US20040138128 for inducing tissue formation; progenitor cells; interleukins; kits |
| 07/15/2004 | US20040138127 Novel antiangiogenic peptides, polypeptides encoding same and methods for inhibiting angiogenesis |
| 07/15/2004 | US20040138126 Family of immunoregulators designated leukocyte immunoglobulin-like receptors (LIR) |
| 07/15/2004 | US20040138124 immunostimulants used for prophylaxis or prevention diseases related to enzymatic deficiency, to stimulate in vivo hydrolysis of xenobiotics, drugs and toxins, or as antiallergens; metabolic and genetic disorders |
| 07/15/2004 | US20040138123 Fibroblast growth factor peptide fragments having deletions in the amino acid sequences, conjugates with ricin, diphtheria or saporin, and carrier mixtures, used as wound heling agents or antiproliferative agents |
| 07/15/2004 | US20040138122 Methods for treating viral infection using IL-28 and IL-29 |
| 07/15/2004 | US20040138121 administering to mammals antitumor agents comprising mixtures of endothelin agonists, anticarcinogenic agents and optionally angiogenesis inhibitors |
| 07/15/2004 | US20040138120 Hepatocyte growth factor variants |
| 07/15/2004 | US20040138119 Use of hepatitis B X-interacting protein (HBXIP) in modulation of apoptosis |
| 07/15/2004 | US20040138118 polypeptide comprises amino acid sequences having point mutations of cleavage sites for metalloenzymes, used for prophylaxis of metabolic and muscular disorders; bone morphogenetic protein/tolloid or tolloid-like protein complexes |
| 07/15/2004 | US20040138117 administering proteins or polypeptides for prophylaxis or diagnosis of nervous system and gastrointerstinal disorders ; genetic engineering; drug screening |
| 07/15/2004 | US20040138116 Tolerogenic approach for type 1 diabetes |
| 07/15/2004 | US20040138115 DNA sequence comprising endorphin codes for proopiomelanocortin genes (POMC), deleted of the coding regions for adrenocorticotropic hormone (ACTH) and beta-melanocyte stimulating hormone ( beta -MSH); anlagesics; gene therapy |
| 07/15/2004 | US20040138114 nucleotide sequences codes for polypeptide used for diagnosis and prophylaxis of autoimmune diseases |
| 07/15/2004 | US20040138113 Administering heterodimeric polypeptides and optionally as mixtures with steroids, to mammals, as antiinflammatory agents; side effect reduction |
| 07/15/2004 | US20040138112 Vaccines |
| 07/15/2004 | US20040138111 Composition and method to alter lean body mass and bone properties in a subject |
| 07/15/2004 | US20040138110 administering plasminogen activator inhibitors comprising cyclic peptides as antitumor agents; tissue-targeted therapy |
| 07/15/2004 | US20040138109 Viricides such as ciluprevir in solutions of polyethylene glycol, ethanol, propylene glycol, water and/or mixtures, used for prophylaxis or prevention of hepatitis C virus (HCV) infections |
| 07/15/2004 | US20040138108 Pro-drug and use thereof as a medicament |
| 07/15/2004 | US20040138107 Dab9 derivatives of lipopeptide antibiotics and methods of making and using the same |
| 07/15/2004 | US20040138106 Glycoprotein synthesis |
| 07/15/2004 | US20040138105 Modulators of polysaccharides and uses thereof |
| 07/15/2004 | US20040138104 Peptides |
| 07/15/2004 | US20040138103 Compositions containing peptide copper complexes and metalloproteinase inhibitors and methods related thereto |
| 07/15/2004 | US20040138101 Prophylaxis of bone disorders comprising administering insulin and derivatives, and optionally in combination with peptide growth factors, metabolic antagonist, osteoprotegerins, synovial or antiinflammatory agents, in sustained release form |
| 07/15/2004 | US20040138100 biochemical conjugates comprising protein carriers such as albumin complexed with peptides that stimulate the biosynthesis or gene expression of insulin, used as sustained release agents for prophylaxis of metabolic disorders; bioavailability |
| 07/15/2004 | US20040138099 Administering sustained release insulin and derivatives for prophylaxis metabolic disorders; side effect reduction; therapy |
| 07/15/2004 | US20040138098 Pharmaceutical compositions including low dosages of desmopressin |
| 07/15/2004 | US20040138097 deactivation of muscles by surgery or by administering botulin toxin, for prophylaxis of neuropathic pain |
| 07/15/2004 | US20040138096 Immunoregulator |
| 07/15/2004 | US20040138095 Colloidal suspension of nanoparticles based on an amphiphilic copolymer |
| 07/15/2004 | US20040137596 Method for purifying an enzyme, a purified enzyme produced thereby, and use of this enzyme |
| 07/15/2004 | US20040137589 Human myosin-like polypeptide expressed predominantly in heart and muscle |
| 07/15/2004 | US20040137581 Interferon variants with improved properties |
| 07/15/2004 | US20040137580 for treating or preventing hyperacute rejection; solid phase synthesis; genetic engineering |
| 07/15/2004 | US20040137579 Protein complexes having factor VIII:C activity and production thereof |
| 07/15/2004 | US20040137574 for drug screening G-protein coupled receptors (GPCRs) inhibitors |
| 07/15/2004 | US20040137573 for drug screening treatments for pain, neuropathy, rheumatoid/osteo arthritis, stroke, inflammation, asthma, allergy, urogenital disorders, incontinence, hypertension, hypotension, perivasular disease; animal models; kits |
| 07/15/2004 | US20040137564 for diagnosing, treating, or preventing cell proliferative, neurological, cardiovascular, gastrointestinal, autoimmune/inflammatory, and metabolic disorders, and viral infections;solid phase synthesis |
| 07/15/2004 | US20040137563 Endogenous and non-endogenous versions of human G protein-coupled receptors |
| 07/15/2004 | US20040137562 Genetically-engineered mhc molecules |
| 07/15/2004 | US20040137557 Remodeling and glycoconjugation of peptides |
| 07/15/2004 | US20040137530 for diagnostic assays/genetically engineering drugs and vaccines |
| 07/15/2004 | US20040137522 Genes and proteins altering Tau-related neurodegeneration |
| 07/15/2004 | US20040137516 DNA sequences from staphylococcus aureus bacteriophage 44AHJD that encode anti-microbial polypeptides |
| 07/15/2004 | US20040137501 Antisense modulation of TRADD expression |
| 07/15/2004 | US20040137500 for drug screening G-protein coupled receptors (GPCRs) compounds; genetic engineering |
| 07/15/2004 | US20040137495 Meg-4 protein |
| 07/15/2004 | US20040137492 Novel polypeptide |
| 07/15/2004 | US20040137489 through comparative global WNT gene signaling antagonist expression profiling (soluble frizzled related protein 3 (SFRP-3/FRZB) or human homologue of Dickkopf-1 (DKK1)); gene expression inhibition |
| 07/15/2004 | US20040137487 hKCa3/KCNN3 small conductance calcium activated potassium channel: a diagnostic marker and therapeutic target |
| 07/15/2004 | US20040137485 consisting of a substantially uncharged antisense oligomer with ratio of uncharged linkages to charged linkages in the oligomer is at least 4:1, preferably at least 5:1, and more preferably at least 8:1 |
| 07/15/2004 | US20040137455 Diagnosis of cancer or benign tumor using the aberrant expression product of the klk4 gene |
| 07/15/2004 | US20040137450 Als2 gene and amyotrophic lateral sclerosis type 2 |
| 07/15/2004 | US20040137446 Fab I and inhibition of apicomplexan parasites |
| 07/15/2004 | US20040137426 Gp41 peptides and methods based thereon for inhibiting HIV fusion to target cells |
| 07/15/2004 | US20040137423 Compositions and methods for modulating HDL cholesterol and triglyceride levels |
| 07/15/2004 | US20040137095 Phytochemotherapy for cancer |
| 07/15/2004 | US20040137074 Osteoprotegerin in milk |
| 07/15/2004 | US20040137071 Nanocapsule encapsulation system and method |